Form D · Biotechnology

NeuroMetrix, Inc.

Waltham, MA · CIK 0001289850

Offering snapshot reported Sep 23, 2009 · SEC filing

Reported sold
$18.7M
Offering amount: $18.7M
Investors reported
16
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 9, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 23, 2009Initial$18,680,003No comparison16SEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$1.24M (estimated)
Finders' fees
$0
Form D file number
021-134670
In addition to the Sales Commissions, the Recipients also received warrants to purchase common stock of the Company, pursuant to the terms of the Offering.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Canaccord Adams, Inc.1020Jeffrey Barlow · CRD 2277052
Ladenburg Thalman & Co. Inc.505Edwin H. Gordon · CRD 1292858

Source: Form D, filed Sep 23, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David E. Goodman Director
Shai N. Gozani Director, Executive
Thomas T. Higgins Executive
Allen J. Hinkle Director
Charles R. La Mantia Director
W. Mark Lortz Director
Timothy R. Surgenor Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
62 Fourth Avenue
Waltham, MA, 02451